Cambridge Investment Research Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Sell |
5,682
-1,122
| -16% | -$44.2K | ﹤0.01% | 3244 |
|
|
2025
Q1 | $205K | Sell |
6,804
-961
| -12% | -$29K | ﹤0.01% | 3192 |
|
|
2024
Q4 | $271K | Sell |
7,765
-1,973
| -20% | -$68.9K | ﹤0.01% | 2918 |
|
|
2024
Q3 | $390K | Sell |
9,738
-310
| -3% | -$12.4K | ﹤0.01% | 2616 |
|
|
2024
Q2 | $479K | Buy |
10,048
+736
| +8% | +$35.1K | ﹤0.01% | 2334 |
|
|
2024
Q1 | $404K | Sell |
9,312
-1,722
| -16% | -$74.7K | ﹤0.01% | 2459 |
|
|
2023
Q4 | $558K | Buy |
11,034
+4,387
| +66% | +$222K | ﹤0.01% | 2100 |
|
|
2023
Q3 | $302K | Sell |
6,647
-827
| -11% | -$37.6K | ﹤0.01% | 2486 |
|
|
2023
Q2 | $307K | Sell |
7,474
-1,000
| -12% | -$41.1K | ﹤0.01% | 2507 |
|
|
2023
Q1 | $303K | Sell |
8,474
-1,081
| -11% | -$38.7K | ﹤0.01% | 2485 |
|
|
2022
Q4 | $361K | Sell |
9,555
-1,367
| -13% | -$51.6K | ﹤0.01% | 2278 |
|
|
2022
Q3 | $483K | Sell |
10,922
-200
| -2% | -$8.85K | ﹤0.01% | 1959 |
|
|
2022
Q2 | $412K | Buy |
11,122
+655
| +6% | +$24.3K | ﹤0.01% | 2113 |
|
|
2022
Q1 | $388K | Buy |
10,467
+20
| +0.2% | +$741 | ﹤0.01% | 2321 |
|
|
2021
Q4 | $318K | Sell |
10,447
-6,420
| -38% | -$195K | ﹤0.01% | 2477 |
|
|
2021
Q3 | $566K | Sell |
16,867
-2,407
| -12% | -$80.8K | ﹤0.01% | 1953 |
|
|
2021
Q2 | $769K | Buy |
19,274
+4,397
| +30% | +$175K | ﹤0.01% | 1734 |
|
|
2021
Q1 | $669K | Buy |
+14,877
| New | +$669K | ﹤0.01% | 1688 |
|
|
2020
Q1 | – | Sell |
-3,773
| Closed | -$228K | – | 2380 |
|
|
2019
Q4 | $228K | Buy |
3,773
+305
| +9% | +$18.4K | ﹤0.01% | 2115 |
|
|
2019
Q3 | $208K | Buy |
3,468
+4
| +0.1% | +$240 | ﹤0.01% | 2087 |
|
|
2019
Q2 | $223K | Sell |
3,464
-47
| -1% | -$3.03K | ﹤0.01% | 1935 |
|
|
2019
Q1 | $285K | Buy |
+3,511
| New | +$285K | ﹤0.01% | 1845 |
|
|
2018
Q4 | – | Sell |
-6,045
| Closed | -$312K | – | 2217 |
|
|
2018
Q3 | $312K | Buy |
6,045
+949
| +19% | +$49K | ﹤0.01% | 1773 |
|
|
2018
Q2 | $212K | Buy |
+5,096
| New | +$212K | ﹤0.01% | 1977 |
|
|
2017
Q4 | – | Sell |
-4,875
| Closed | -$247K | – | 2130 |
|
|
2017
Q3 | $247K | Buy |
4,875
+513
| +12% | +$26K | ﹤0.01% | 1687 |
|
|
2017
Q2 | $222K | Buy |
+4,362
| New | +$222K | ﹤0.01% | 1686 |
|
|
2017
Q1 | – | Sell |
-5,616
| Closed | -$269K | – | 1785 |
|
|
2016
Q4 | $269K | Sell |
5,616
-632
| -10% | -$30.3K | 0.01% | 1340 |
|
|
2016
Q3 | $229K | Buy |
+6,248
| New | +$229K | ﹤0.01% | 1468 |
|
|
2016
Q2 | – | Sell |
-6,221
| Closed | -$252K | – | 1642 |
|
|
2016
Q1 | $252K | Sell |
6,221
-714
| -10% | -$28.9K | 0.01% | 1267 |
|
|
2015
Q4 | $429K | Sell |
6,935
-1,155
| -14% | -$71.4K | 0.01% | 922 |
|
|
2015
Q3 | $327K | Buy |
8,090
+1,059
| +15% | +$42.8K | 0.01% | 986 |
|
|
2015
Q2 | $405K | Buy |
7,031
+657
| +10% | +$37.8K | 0.01% | 922 |
|
|
2015
Q1 | $406K | Sell |
6,374
-922
| -13% | -$58.7K | 0.01% | 901 |
|
|
2014
Q4 | $450K | Buy |
7,296
+629
| +9% | +$38.8K | 0.01% | 831 |
|
|
2014
Q3 | $259K | Sell |
6,667
-55
| -0.8% | -$2.14K | 0.01% | 1175 |
|
|
2014
Q2 | $232K | Buy |
+6,722
| New | +$232K | 0.01% | 1126 |
|